Coxa Hospital for Joint Replacement, Tampere, Finland.
Faculty of Social Sciences, University of Tampere, Tampere, Finland.
Scand J Surg. 2019 Dec;108(4):313-320. doi: 10.1177/1457496918816918. Epub 2018 Dec 6.
Previous studies have reported lower implant survival rates, residual pain, and higher patient dissatisfaction rates following knee arthroplasty in younger knee arthroplasty patients. We aimed to assess the real-world effectiveness of knee arthroplasty in a prospective non-selected cohort of patients aged 65 years or less with 2-year follow-up.
In total, 250 patients (272 knees) aged 65 years or less were enrolled into this prospective cohort study. Patient-reported outcome measures were used to assess the outcome.
The mean Oxford Knee Score and all Knee Injury and Osteoarthritis Outcome Score subscales increased significantly (p < 0.001) from preoperative situation to the 2-year follow-up. Significant increase (p < 0.001) in physical activity was detected in High-Activity Arthroplasty Score and RAND-36 Physical Component Score (PCS). Pain was also significantly (p < 0.001) relieved during the follow-up. Total disappearance of pain was rare at 2 years. Patients with milder (Kellgren-Lawrence grade 2) osteoarthritis were less satisfied and reported poorer patient-reported outcome measure than those with advanced osteoarthritis (Kellgren-Lawrence grade 3-4). There was no difference in the outcome (any patient-reported outcome measure) between patients who underwent total knee arthroplasty and those who received unicondylar knee arthroplasty.
We found that measured with a wide set of patient-reported outcome measures, both total knee arthroplasty and unicondylar knee arthroplasty resulted in significant pain relief, as well as improvement in physical performance and quality of life in patients aged 65 years or less. Real-world effectiveness of these procedures seems to be excellent. 15% of patients still had residual symptoms and were dissatisfied with the outcome at 2 years after the operation.
既往研究报道,膝关节置换术在年轻膝关节置换患者中,其植入物存活率较低,残留疼痛较高,患者满意度较低。我们旨在评估在一个前瞻性、非选择性的 65 岁或以下患者队列中,膝关节置换术的真实有效性,随访时间为 2 年。
共纳入 250 例(272 膝)65 岁或以下的患者进行前瞻性队列研究。采用患者报告的结局测量来评估结果。
牛津膝关节评分(Oxford Knee Score)和所有膝关节损伤和骨关节炎结果评分(Knee Injury and Osteoarthritis Outcome Score)亚量表的均值从术前到 2 年随访时均显著增加(p<0.001)。在高活动评分(High-Activity Arthroplasty Score)和 RAND-36 生理成分评分(Physical Component Score,PCS)中检测到的身体活动显著增加(p<0.001)。在随访过程中疼痛也显著缓解(p<0.001)。2 年后疼痛完全消失的情况很少见。膝关节轻度(Kellgren-Lawrence 分级 2)骨关节炎患者的满意度低于膝关节中重度(Kellgren-Lawrence 分级 3-4)骨关节炎患者,且报告的患者报告结局测量结果更差。接受全膝关节置换术和单髁膝关节置换术的患者之间在任何患者报告结局测量结果上均无差异。
我们发现,使用广泛的患者报告结局测量结果衡量,全膝关节置换术和单髁膝关节置换术均能显著缓解疼痛,并改善 65 岁或以下患者的身体机能和生活质量。这些手术的真实有效性似乎非常出色。术后 2 年仍有 15%的患者存在残留症状,对手术结果不满意。